Alerts will be sent to your verified email
Verify Email
METROPOLIS
|
Metropolis Health.
|
Dr. Lal Pathlabs
|
Thyrocare Tech.
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
17.42 % | 20.49 % | 20.41 % |
|
5yr Avg Net Profit Margin
|
13.94 % | 16.53 % | 18.13 % |
|
Price to Book
|
8.37 | 12.61 | 12.5 |
|
P/E
|
73.21 | 53.41 | 64.21 |
|
5yr Avg Cash Conversion Cycle
|
-103.57 Days | -128.38 Days | -55.2 Days |
|
5yr Average Interest Coverage Ratio
|
11.6 | 19.96 | 65.11 |
|
5yr Avg ROCE
|
18.91 % | 26.99 % | 26.01 % |
|
5yr Avg Operating Profit Margin
|
25.91 % | 26.87 % | 30.0 % |
|
5 yr average Debt to Equity
|
0.08 | 0.08 | 0.01 |
|
5yr CAGR Net Profit
|
-4.56 % | 10.81 % | -4.08 % |
|
5yr Average Return on Assets
|
10.32 % | 15.26 % | 14.94 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
48.89 % | 53.79 % | 71.06 % |
|
Share Pledged by Promoters
|
1.18 % | 0.0 | 100.0 % |
|
Change in Promoter Holding (3 Yrs)
|
-0.9 % | -1.26 % | -0.12 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
17.05 % | 12.21 % | 7.94 % |
|
Metropolis Health.
|
Dr. Lal Pathlabs
|
Thyrocare Tech.
|
|---|